Koltan names Frank Karbe to board
This article was originally published in Scrip
Executive Summary
New Haven, Connecticut-based Koltan Pharmaceuticals has named Frank Karbe, former chief financial officer of Exelixis, to its board of directors. Mr Karbe has more than two decades of international experience in finance and business development. Previously, Mr Karbe held various positions in the finance department of The Royal Dutch/Shell Group in Europe. And since January 2010, he has been a member of the board and chair of the audit committee for Tekmira Pharmaceuticals, a publicly held biopharmaceutical company.
You may also be interested in...
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
In Vivo’s 2024 Rising Leaders
The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.